208 related articles for article (PubMed ID: 2971659)
21. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component.
Lambris JD; Lao Z; Oglesby TJ; Atkinson JP; Hack CE; Becherer JD
J Immunol; 1996 Jun; 156(12):4821-32. PubMed ID: 8648130
[TBL] [Abstract][Full Text] [Related]
22. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1977 Jul; 146(1):257-70. PubMed ID: 301546
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
24. Functional properties of membrane-associated complement receptor CR1.
Iida K; Nussenzweig V
J Immunol; 1983 Apr; 130(4):1876-80. PubMed ID: 6220069
[TBL] [Abstract][Full Text] [Related]
25. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
26. Interaction between C3 and IL-2; inhibition of C3b binding to CR1 by IL-2.
Bartók I; Erdei A; Mouzaki A; Osawa H; Szölösi J; Eigentler A; Diamantstein T; Dierich MP; Gergely J
Immunol Lett; 1989 May; 21(2):131-7. PubMed ID: 2527811
[TBL] [Abstract][Full Text] [Related]
27. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
Vik DP; Fearon DT
J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
[TBL] [Abstract][Full Text] [Related]
28. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD
Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus regulates activation and processing of the third component of complement.
Mold C; Bradt BM; Nemerow GR; Cooper NR
J Exp Med; 1988 Sep; 168(3):949-69. PubMed ID: 2844953
[TBL] [Abstract][Full Text] [Related]
30. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
Medof ME; Nussenzweig V
J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
[TBL] [Abstract][Full Text] [Related]
31. Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3b.
Currie MS; Rustagi PK; Wojcieszak R; Ziolkowski L; Ross GD; Logue GL
Blood; 1988 Mar; 71(3):786-90. PubMed ID: 3345346
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of complement component C3 and C3 fragments by a human platelet protein kinase. Inhibition of factor I-mediated cleavage of C3b.
Ekdahl KN; Nilsson B
J Immunol; 1995 Jun; 154(12):6502-10. PubMed ID: 7539023
[TBL] [Abstract][Full Text] [Related]
33. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
Koistinen V; Wessberg S; Leikola J
Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
[TBL] [Abstract][Full Text] [Related]
34. Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b.
Seya T; Okada M; Nishino H; Atkinson JP
J Biochem; 1990 Feb; 107(2):310-5. PubMed ID: 2141838
[TBL] [Abstract][Full Text] [Related]
35. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin.
Minta JO; Man D; Movat HZ
J Immunol; 1977 Jun; 118(6):2192-8. PubMed ID: 864257
[TBL] [Abstract][Full Text] [Related]
36. Cleavage of membrane bound C3bi, an intermediate of the third component of complement, to C3c and C3d-like fragments by crude leucocyte lysosomal lysates and purified leucocyte elastase.
Carlo JR; Spitznagel JK; Studer EJ; Conrad DH; Ruddy S
Immunology; 1981 Oct; 44(2):381-91. PubMed ID: 7028603
[TBL] [Abstract][Full Text] [Related]
37. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
[TBL] [Abstract][Full Text] [Related]
38. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).
Kinoshita T; Lavoie S; Nussenzweig V
J Immunol; 1985 Apr; 134(4):2564-70. PubMed ID: 3156184
[TBL] [Abstract][Full Text] [Related]
39. Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function.
Nilsson B; Ekdahl KN; Svarvare M; Bjelle A; Nilsson UR
Clin Exp Immunol; 1990 Nov; 82(2):262-7. PubMed ID: 2146995
[TBL] [Abstract][Full Text] [Related]
40. Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjögren's syndrome.
Thomsen BS; Oxholm P; Manthorpe R; Nielsen H
Arthritis Rheum; 1986 Jul; 29(7):857-62. PubMed ID: 2943291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
